Antibody-Mediated Rejection in Solid Organ Transplant

Area of Science:

• Immunology
• Transplant Surgery
• Medical Science

Background:

• Human organ transplantation has advanced significantly, overcoming early immune system barriers.
• Refined immunosuppressive therapies and donor-recipient matching have reduced hyperacute and acute rejection.
• Antibody-mediated rejection (AMR) persists as a major obstacle to long-term graft survival.

Purpose of the Study:

• To provide a comprehensive overview of the immune system's role in transplantation.
• To elucidate the mechanisms underlying transplant rejection, particularly AMR.
• To detail current strategies for the prevention, detection, and treatment of AMR in solid organ transplant recipients.

Main Methods:

• Review of immunological principles relevant to organ transplantation.
• Discussion of the pathophysiology of hyperacute, acute, and antibody-mediated rejection.
• Synthesis of current clinical practices in managing AMR.

Main Results:

• Significant progress has been made in controlling immune responses post-transplant.
• While hyperacute and acute rejection are largely managed, AMR remains a critical clinical issue.
• Effective management of AMR is crucial for improving long-term outcomes in solid organ transplantation.

Conclusions:

• Understanding the immune system is fundamental to successful organ transplantation.
• Targeted strategies are needed to overcome the challenges posed by antibody-mediated rejection.
• Continued research and clinical advancements are essential for enhancing graft and patient survival.